Published in Lab Invest on December 01, 1983
Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest (1995) 1.22
Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut (1992) 0.94
Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases. Am J Pathol (1985) 0.89
The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential. Br J Cancer (1992) 0.77
Use of immunohistochemical staining panel for characterisation of ovarian neoplasms. J Clin Pathol (1988) 0.76
Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma. Am J Pathol (1988) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys (1998) 3.82
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res (1999) 3.58
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci (1993) 2.62
Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res (1999) 2.55
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol (1998) 2.44
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol (2001) 2.31
Mycosis fungoides palmaris et plantaris. Arch Dermatol (1995) 2.25
Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst (1995) 2.25
Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst (1989) 2.19
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. Int J Cancer (1997) 2.13
Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol (1997) 2.10
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol (2000) 2.05
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res (2001) 2.01
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81
Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer. J Thorac Cardiovasc Surg (1992) 1.72
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med (1998) 1.69
Cloacogenic carcinoma of the anorectum in homosexual men: an observation of four cases. Dis Colon Rectum (1980) 1.63
Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer (1997) 1.62
Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res (1991) 1.59
p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer (1994) 1.58
Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol (1983) 1.56
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst (1991) 1.55
Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst (1994) 1.52
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res (2000) 1.52
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg (2001) 1.50
Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology (1977) 1.43
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol (2001) 1.42
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst (1993) 1.42
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology (2001) 1.41
Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol (1985) 1.41
Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology (2000) 1.38
Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res (1991) 1.36
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res (1997) 1.35
A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet (1993) 1.35
Adenomyoepithelioma of the breast. A spectrum of biologic behavior. Am J Surg Pathol (1992) 1.33
Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Pathol (2001) 1.31
Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol (1999) 1.27
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol (1995) 1.26
Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Urology (2001) 1.22
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol (1994) 1.21
Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol (1986) 1.20
Peanut lectin-binding sites in large bowel carcinoma. Lab Invest (1982) 1.20
Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res (1998) 1.19
ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene (2006) 1.19
Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am (1993) 1.17
Colonic "precancer" in Crohn's disease. Gastroenterology (1981) 1.14
Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate (1997) 1.14
Warty (condylomatous) squamous cell carcinoma of the penis: a report of 11 cases and proposed classification of 'verruciform' penile tumors. Am J Surg Pathol (2000) 1.13
Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer (1993) 1.13
Carcinoids: the association of histologic growth pattern and survival. Cancer (1983) 1.13
Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum (1979) 1.12
Intrarenal schwannoma: a report of four cases including three cellular variants. Mod Pathol (2000) 1.11
Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol (1999) 1.09
Letter: Chronic phycomycosis in a controlled diabetic. Ann Intern Med (1974) 1.08
Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol (1997) 1.08
Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst (1995) 1.07
Allelic deletions in renal tumors: histopathological correlations. Cancer Res (1993) 1.07
Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.06
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer (2009) 1.04
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer (1993) 1.04
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene (1998) 1.03
Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology (1997) 1.03
Glue sniffer's neuropathy. Neurology (1976) 1.02
Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. Clin Cancer Res (1999) 1.02
Tubular carcinoma of the breast. Cancer (1978) 1.02
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol (1994) 1.01
In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer (2008) 1.01
Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment Pharmacol Ther (1999) 1.01
Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst (1993) 1.01
Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol (1996) 1.00
Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ). Ann Intern Med (1974) 1.00
Oncocytic adrenal cortical adenoma. Ultrastruct Pathol (1992) 0.99
Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol (2000) 0.99
Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors. Am J Surg Pathol (2000) 0.99
Primary combined malignant melanoma and ductal carcinoma of the breast. A report of two cases. Cancer (1996) 0.98
Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst (1994) 0.98
Can p53 help select patients with invasive bladder cancer for bladder preservation? J Urol (1999) 0.98
Leukemic differentiation of a mediastinal germ cell tumor. Genes Chromosomes Cancer (1989) 0.96
Renal myxoma. A report of two cases and review of the literature. Am J Surg Pathol (1994) 0.96
Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res (1994) 0.96
Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol (1998) 0.95
Lectins as probes in histochemistry and immunohistochemistry: the peanut (Arachis hypogaea) lectin. Hum Pathol (1984) 0.95
The "WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion. Hum Pathol (1999) 0.94
Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer (1997) 0.94
Comparative genomic hybridization for genetic analysis of renal oncocytomas. Genes Chromosomes Cancer (1996) 0.93
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology (1997) 0.93
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol (1994) 0.93
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst (1990) 0.93
Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status. Lab Invest (1986) 0.92
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol (2001) 0.92